Renalis Revenue and Competitors
Estimated Revenue & Valuation
- Renalis's estimated annual revenue is currently $1.5M per year.
- Renalis's estimated revenue per employee is $84,000
Employee Data
- Renalis has 18 Employees.
- Renalis grew their employee count by 38% last year.
Renalis's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. VP | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CEO, Founder | Reveal Email/Phone |
4 | CMO, Co-Founder | Reveal Email/Phone |
5 | Director Product Design | Reveal Email/Phone |
6 | Lead Product Designer | Reveal Email/Phone |
7 | Clinical Research Associate | Reveal Email/Phone |
8 | Lead Software Architect | Reveal Email/Phone |
Renalis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1M | 12 | N/A | N/A | N/A |
#2 | $34.2M | 222 | 8% | N/A | N/A |
#3 | $27.5M | 183 | -19% | $25.3M | N/A |
#4 | $28M | 182 | N/A | N/A | N/A |
#5 | $4.5M | 42 | 11% | $27M | N/A |
#6 | $9.1M | 75 | 23% | $8.3M | N/A |
#7 | $70.7M | 404 | N/A | N/A | N/A |
#8 | $8.1M | 64 | 3% | N/A | N/A |
#9 | $2.5M | 26 | N/A | N/A | N/A |
#10 | $161.4M | 806 | 48% | $491M | N/A |
What Is Renalis?
Renalis is creating a suite of prescribed digital therapeutics (PDT) designed for patients with pelvic health disorders such as overactive bladder (OAB), fecal incontinence, fibroids, endometriosis or chronic pelvic pain. The company's first go-to-market platform for fibroids/endo will be available 3Q20, followed by another for OAB, for which the company anticipates seeking FDA approval in 2021 following clinical trials. Renalis is based in Chicago at MATTER, but serves a global market.
keywords:N/AN/A
Total Funding
18
Number of Employees
$1.5M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 18 | -10% | N/A |
#2 | $0.6M | 18 | -10% | $41.5M |
#3 | $2.7M | 18 | N/A | N/A |
#4 | $2.2M | 18 | N/A | N/A |
#5 | $2.2M | 18 | N/A | N/A |